Prospective clinical research on safety and efficacy of TAPCOM Combination Ophthalmic Solution switched from Xalatan Ophthalmic Solutio
Not Applicable
- Conditions
- primary open angle glaucoma or ocular hypertension
- Registration Number
- JPRN-UMIN000016465
- Lead Sponsor
- Hiroshima University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 85
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with allergy to the ingredients used in the present study Patients who are contraindicated to Beta blockers Patients who the investigator consider ineligible for enrollment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction of intraocular pressure Topical and systemic adverse event
- Secondary Outcome Measures
Name Time Method